Insulin initiation titration guidelines
Reading File
Finding Sources
Finding Sources
Searching PubMed
"insulin" AND "titration" AND "type 2 diabetes"
Reading File
Finding Sources
Reading Article
PMID: 40273351
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
I now have all the content needed for a comprehensive answer. Let me compile it.
Insulin Initiation & Titration Guidelines
This guide covers the step-wise approach from first insulin dose through full basal-bolus intensification, primarily for type 2 diabetes mellitus (T2DM), with notes on T1DM.
1. When to Initiate Insulin
Insulin should be considered:
- When A1C remains >7% despite maximal oral/non-insulin injectable therapy
- At diagnosis if symptomatic hyperglycemia is severe (fasting glucose >250 mg/dL, random >300 mg/dL, or DKA/HHS)
- Beta-cell failure is evident (thin patient, weight loss, low C-peptide)
- Pregnancy with gestational diabetes uncontrolled by diet
- As initial therapy in some patients (early intensive insulin can "rest" beta cells and may preserve function)
2. Types of Insulin Relevant to Initiation
| Type | Examples | Onset | Peak | Duration |
|---|---|---|---|---|
| Rapid-acting analog | Lispro, Aspart, Glulisine | 10-30 min | 60 min | 3-5 h |
| Short-acting (regular) | Humulin R, Novolin R | 30-60 min | 2-3 h | 6-8 h |
| Intermediate | NPH | 2-4 h | 4-10 h | 12-24 h |
| Long-acting analog (basal) | Glargine (Lantus/Toujeo), Detemir (Levemir) | 1-4 h | Flat | ~24 h |
| Ultra-long acting | Degludec (Tresiba) | 1-4 h | Flat | >42 h |
| Premixed analogs | Lispro 75/25, Lispro 50/50, Aspart 70/30 | ~15 min | Biphasic | - |
Basal analogs (glargine, detemir) have a flat time-action profile with no pronounced peak, more closely mimicking physiological basal insulin - this reduces nocturnal hypoglycemia risk versus NPH.
- Textbook of Family Medicine 9e, p. 981
- Rosen's Emergency Medicine, p. 2538
3. Starting Basal Insulin (Step 1 - First Insulin in T2DM)
Standard Starting Doses
The preferred first insulin in T2DM is a once-daily basal analog (glargine or detemir):
- Standard: 10 units/day at bedtime (9:00 PM), OR
- Weight-based: 0.1-0.2 units/kg/day once daily
- Obese/insulin-resistant patients: 0.4 units/kg/day (when rapid correction needed)
These are widely endorsed by multiple diabetes societies and colleges.
- Rosen's Emergency Medicine, p. 2538
- Textbook of Family Medicine 9e, p. 981
4. Basal Insulin Titration Protocols
Three well-validated protocols used in primary care:
Protocol 1 - Canadian INSIGHT Trial
| Parameter | Detail |
|---|---|
| Starting dose | 10 units at 9:00 PM |
| Titration rule | Increase by 1 unit/day until fasting glucose ≤110 mg/dL |
| Simpler variant | Increase by 5 units every Monday |
| Target FBG | ≤110 mg/dL |
Protocol 2 - PREDICTIVE 303 Protocol
| Parameter | Detail |
|---|---|
| Starting dose | 10 units at 9:00 PM |
| SMBG frequency | Every morning (3-day rolling average) |
| Adjustment rule | Based on 3-day average fasting glucose: |
| - FBG < 80 mg/dL | Decrease by 3 units |
| - FBG 80-110 mg/dL | No adjustment |
| - FBG > 110 mg/dL | Increase by 3 units |
| Note | Protocol is perpetual - patients do not stop self-adjusting without clinician instruction |
The TITRATE study variant set a tighter target: FBG 70-90 mg/dL.
Protocol 3 - Insulin-Resistant Weight Protocol (obese patients)
| Parameter | Detail |
|---|---|
| Starting dose | 0.4 units/kg at 9:00 PM |
| Titration | Increase by 5 units each Monday |
| Maximum dose | 60 units/day |
| If 60 units reached | Add prandial insulin (basal-plus) OR reduce basal by 20% and add GLP-1 agonist |
General titration principle (multi-society consensus):
Start at 10 units/day; titrate upward by 1-3 units every 1-3 days; target HbA1c <6.5-7%.
- Textbook of Family Medicine 9e, p. 981 (Table 34-17)
- Rosen's Emergency Medicine, p. 2538
Key evidence update (2025): A network meta-analysis in Diabetes Care (PMID 40273351) found that self-titration at least twice weekly with healthcare provider support produces the greatest HbA1c reduction compared to all other strategies, without increasing severe hypoglycemia. This "ST/High/S-HCP" approach should be prioritized where feasible.
5. When to Add Prandial Insulin (Step 2 Intensification)
Approximately 60% of T2DM patients achieve A1C ≤7% with basal insulin plus oral agents. For the remainder, consider adding prandial insulin when:
- A1C remains >7% despite fasting glucose target being met (<100 mg/dL)
- Basal dose has exceeded 60 units/day
- Repeated nocturnal hypoglycemia during titration
- A1C goal not achieved within 1 year of basal insulin start
- BeAM factor >55 mg/dL (bedtime minus morning glucose >55 mg/dL - signals significant postprandial contribution)
An alternative to prandial insulin: add an incretin-based agent (GLP-1 RA or DPP-4 inhibitor) to basal insulin.
- Textbook of Family Medicine 9e, p. 982 (Table 34-18)
6. Basal-Plus Regimen (One Prandial Injection)
- Use structured SMBG: check before and 2 hours after each meal for 3 days
- Identify the meal with the highest delta (Δ = 2-hour postprandial minus premeal glucose)
- Add rapid-acting analog at that meal only
- Starting prandial dose: typically 4-6 units before the largest meal, or as per insulin-to-carbohydrate ratio
- Inject rapid-acting analog 15 minutes before the meal (unless premeal glucose <80 mg/dL)
- Target: postprandial glucose rise (Δ) of ≤50 mg/dL
7. Basal-Bolus Regimen (Full Physiological Replacement)
For patients not controlled on basal-plus:
- Basal insulin: glargine or detemir once daily (continued)
- Prandial insulin: rapid-acting analog before each meal (3 injections/day)
- Correction dose: Added to the prandial dose when premeal glucose exceeds target
- Example: Target BG = 150 mg/dL; premeal BG = 200 mg/dL → correction = 2 units (for each 50 mg/dL above target)
- Total bolus = baseline prandial dose + correction dose
- Check SMBG 2 hours after eating to confirm no overcorrection
Initial total daily dose (TDD) estimate for T1DM basal-bolus:
- 0.5-0.7 units/kg/day total
- ~50% as basal, ~50% divided among 3 meals
8. Premixed Insulin - Alternative Approach
Premixed analogs (lispro 75/25, lispro 50/50, aspart 70/30) combine a rapid-acting component and a protamine-delayed component in one injection.
Candidates: A1C 8.5-10%, regular meal schedule, 3 meals/day, consistent physical activity routine
Timing: Inject 15 minutes before meals
Advantage: Two insulins for one copayment; simpler regimen
Caution: Less flexibility; higher hypoglycemia rates with human premixed (2-14%) vs. analog premixed (2-8%)
- Textbook of Family Medicine 9e, p. 983
9. Keys to Successful Insulin Initiation (Clinical Pearls)
| Principle | Detail |
|---|---|
| Self-titration | Allow and encourage patients to self-titrate with a written algorithm - this should be the rule, not the exception |
| Use analogs | Regular human insulin increases hypoglycemia risk versus analogs |
| Pen delivery | Insulin pens improve accuracy and adherence vs. vials/syringes |
| Lag time | Rapid analogs: inject 15 min before meals (not at the table) |
| Renal impairment | Reduce insulin dose by ~10%; monitor closely (impaired insulin clearance) |
| GLP-1 RA combination | When adding a GLP-1 RA to basal insulin, reduce basal dose by 20% |
| Weight management | Discontinue TZDs and sulfonylureas when starting insulin to minimize weight gain |
| Agents to continue | Metformin, SGLT2i, DPP-4i, GLP-1 RA, alpha-glucosidase inhibitors can all continue with insulin |
| Reversibility | If dose remains <20 units/day and A1C <7.5%, insulin may eventually be discontinued |
- Textbook of Family Medicine 9e, p. 984 (Table 34-20)
10. Monitoring & Follow-Up
- SMBG frequency: Fasting daily during titration; pre- and 2-hour postprandial when optimizing prandial doses
- A1C: Repeat ~3 months after any regimen change
- Hypoglycemia education: Patients must understand how to recognize (symptoms at ~70 mg/dL), prevent, and treat hypoglycemia (15g fast-acting carbohydrate rule)
- Structured SMBG logs help identify patterns and guide systematic dose adjustments
Sources:
- Textbook of Family Medicine, 9th ed. - Chapter 34, pp. 981-990 (Tables 34-17, 34-18, 34-19, 34-20, 34-25)
- Rosen's Emergency Medicine, Concepts and Clinical Practice - Chapter on DM Management, p. 2538
- Boonpattharatthiti K et al. (2025). Comparison of Insulin Titration Strategies for Glycemic Control in T2DM: Systematic Review and Network Meta-analysis. Diabetes Care. (PMID 40273351)
This is a shared conversation. Sign in to Orris to start your own chat.